Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.550
+0.010 (0.39%)
At close: Aug 14, 2026, 4:00 PM EDT
2.520
-0.030 (-1.18%)
After-hours: Aug 14, 2026, 7:50 PM EDT
CNTB Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, CNTB stock has a consensus rating of "Strong Buy" and an average price target of $7.25. The average 1-year stock price forecast is 184.31% higher than the current stock price, while the lowest is $4.00 (+56.86%) and the highest is $10 (+292.16%).
Price Target: $7.25 (+184.31%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CNTB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 7 | 6 | 7 | 7 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +174.51% | Aug 13, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 | Buy | Maintains | $7 | +174.51% | Aug 13, 2026 |
| BTIG | BTIG | Buy Maintains $10 | Buy | Maintains | $10 | +292.16% | Aug 13, 2026 |
| Lake Street | Lake Street | Buy Maintains $9 | Buy | Maintains | $9 | +252.94% | Jul 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $8 | Buy | Initiates | $8 | +213.73% | Jul 9, 2026 |
Financial Forecast
Revenue This Year
6.06M
from 64.00K
Increased by 9,376.36%
Revenue Next Year
10.88M
from 6.06M
Increased by 79.45%
EPS This Year
-0.15
from -0.14
EPS Next Year
-0.11
from -0.15
EPS and Forward PE are based on non-GAAP adjusted numbers.